Sandoz Omeprazol 20mg

Sandoz is a global leader in generic and biosimilar medicines. Originally part of the Swiss conglomerate Novartis, Sandoz became an independent, publicly traded company in October 2023.

Its Omeprazol product is a gastro-resistant medication used to treat acid-related conditions. While the brand has Swiss roots, manufacturing typically occurs across various specialized facilities in Europe and globally to meet international demand. Sandoz's headquarters remain in Basel, Switzerland, following its spinoff into a standalone entity.